<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01145677</url>
  </required_header>
  <id_info>
    <org_study_id>THoPA-R</org_study_id>
    <nct_id>NCT01145677</nct_id>
  </id_info>
  <brief_title>Efficacy of Topiramate for Hospitalized Patients With Alcoholism</brief_title>
  <acronym>ETHoPA-R</acronym>
  <official_title>Efficacy of Topiramate for Hospitalized Patients With Alcoholism: a 12-Week Randomized, Placebo-Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiang Mai University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiang Mai University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 12-Week, randomized controlled study of topiramate in hospitalized patients with
      alcoholism
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alcohol drink/day</measure>
    <time_frame>12 weeks</time_frame>
    <description>Alcohol drink/day assessed by the use of time line follow back</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Common adverse effect</measure>
    <time_frame>12 week</time_frame>
    <description>Common adverse effect will be assessed by the use of questionaire and self-report</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Alcohol Dependence</condition>
  <arm_group>
    <arm_group_label>Topiramate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topiramate</intervention_name>
    <description>Topiramate 100-300 mg/day orally twice per day</description>
    <arm_group_label>Topiramate</arm_group_label>
    <other_name>Topamax</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients hospitalized due to alcohol-related problem

          -  DSM-IV-TR alcohol dependence

          -  for male: history of alcohol drink &gt;=35/week, female: history of alcohol drink
             &gt;=28/week for at least 1 week during four weeks prior to the admission

          -  AUDIT score at least 8

          -  mild or no alcohol withdrawal symptom

          -  BMI &gt; 18 kg/m2

          -  not pregnant and no plan for pregnancy

          -  intention to decrease or stop drinking

        Exclusion Criteria:

          -  severe psychiatric and cognitive disorders

          -  other substance dependence, except nicotine and caffeine dependence, during 6 months
             prior to enrollment

          -  taking antipsychotics, mood stabilizers, anticonvulsants, opioid analgesics, systemic
             steroids, carbonic anhydrase inhibitors, hydrochlorthiazide, metformin, pioglitazone,
             or disulfiram

          -  unstable medical condition

          -  medical history of narrow angle glaucoma, renal impairment, kidney stones, and
             seizures

          -  moderate to high risk of suicide

          -  under legal process

          -  plan to receive a formal treatment for alcoholism from other treatment settings

          -  pregnancy and nursing woman

          -  abnormal laboratory tests, including blood urea nitrogen, creatinine, electrolytes,
             and fasting blood sugar
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Surinporn Likhitsathian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry, Faculty of Medicine, Chiang Mai University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chiang Mai Drug Dependence Treatment Center</name>
      <address>
        <city>Maerim</city>
        <state>Chiang Mai</state>
        <zip>50180</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharaj Nakorn Chiang Mai Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chiang Mai</state>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Suanprung Psychiatric Hospital</name>
      <address>
        <city>Muang</city>
        <state>ChiangMai</state>
        <zip>50100</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharaj Nakorn Chiang Mai Hospital</name>
      <address>
        <city>Muang</city>
        <state>ChiangMai</state>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2010</study_first_submitted>
  <study_first_submitted_qc>June 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2010</study_first_posted>
  <last_update_submitted>June 22, 2011</last_update_submitted>
  <last_update_submitted_qc>June 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Surinporn Likhitsathian</name_title>
    <organization>Department of Psychiatry, Faculty of Medicine, Chiang Mai University</organization>
  </responsible_party>
  <keyword>Alcohol dependence</keyword>
  <keyword>Alcoholism</keyword>
  <keyword>Topiramate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Topiramate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

